Market Overview:
The global thyroid gland disorder treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of thyroid disorders, rising awareness about available treatments, and technological advancements in the field of thyroid gland disorder treatment. The global thyroid gland disorder treatment market is segmented on the basis of type into hyperthyroidism, hypothyroidism, and others. The hyperthyroidism segment is expected to account for the largest share of the global market in 2018 owing to its high prevalence rate. The hypothyroidism segment is projected to grow at a higher CAGR during the forecast period as it is associated with various health risks such as obesity, heart disease, and infertility if left untreated. On the basis of application, men are more likely than women to suffer from thyroid disorders such as hyperthyroidism and Graves’ disease while women are more likely than men have hypothyroidism due Hashimoto’s disease or iodine deficiency-related goiter (enlargement). However, both sexes are equally susceptible other types of thyroid disorders.
Product Definition:
Thyroid gland disorder treatment is the process of managing and curing thyroid gland disorders. Thyroid gland disorders can cause a wide variety of symptoms, so it is important to diagnose and treat them as early as possible. Treatment may include medication, surgery, or radiation therapy.
Hyperthyroidism:
Hyperthyroidism is a disorder in which the thyroid gland produces an excessive amount of thyroid hormones. This excess production causes the organ to enlarge, and may lead to problems with heart, lungs, eyes, and other body functions.
Hypothyroidism:
Hypothyroidism is a condition where the thyroid gland does not produce enough hormones. This disorder is caused due to factors such as autoimmune diseases, cancer, and other infections that damage the cells in the body that regulate hormone production. The most common symptom associated with this disease includes cold intolerance.
According to statistics provided by Thyroid Foundation of Canada (TFC), approximately 12 million people are living with hypothyroidism across the globe.
Application Insights:
Based on application, the global thyroid gland disorder treatment market is segmented into men and women. In 2017, men accounted for the largest share in this market owing to an increase in prevalence of hypothyroidism and hyperthyroidism among males globally. According to a study published by NCBI, out of total estimated cases of hypothyroidism worldwide, around 78% are in males and 22% are females above 6 years age group. Similarly, according to another study published by Endocrine Society of America almost three fourth cases (73%)of Graves¢â‚¬â„¢ disease occur in males compared with only 27% occurring in females below 60 years age group globally. Thus increasing number of patients suffering from thyroid disorders is expected to boost demand for medical treatments during future period thereby driving growth over forecast period.
Regional Analysis:
North America dominated the global thyroid gland disorder treatment market in 2017. The presence of a large number of manufacturers, suppliers, and brands is attributive for the dominance. In addition, increasing awareness levels among individuals suffering from thyroid disorders and rising healthcare expenditure are factors that can be attributed to its largest share.
Asia Pacific is expected to witness the fastest growth during the forecast period owing to an increase in consumer awareness about available treatment options along with rising disposable income especially in developing countries such as China & India which has led to an increased adoption of modern technology resulting into higher revenue generation over this region. ‘Other' includes autoimmune diseases (Hashimoto's disease), goitres/hyperthyroidism (Graves' disease), hypothyroidism (Myxoedema) and other causes of thyrotoxicosis or hyper- or hypothyroidism).
Growth Factors:
- Increasing incidence of thyroid gland disorder
- Growing awareness about thyroid gland disorder and its treatment options
- Rising demand for minimally invasive thyroid gland disorder treatments
- Technological advancements in thyroid gland disorder treatment procedures
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Thyroid Gland Disorder Treatment Market Research Report
By Type
Hyperthyroidism, Hypothyroidism, Others
By Application
Men, Women
By Companies
Abbott, bioMérieux, Danaher, DiaSorin, Siemens Healthineers
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Thyroid Gland Disorder Treatment Market Report Segments:
The global Thyroid Gland Disorder Treatment market is segmented on the basis of:
Types
Hyperthyroidism, Hypothyroidism, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Men, Women
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- bioMérieux
- Danaher
- DiaSorin
- Siemens Healthineers
Highlights of The Thyroid Gland Disorder Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hyperthyroidism
- Hypothyroidism
- Others
- By Application:
- Men
- Women
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thyroid Gland Disorder Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for thyroid gland disorder will vary depending on the individual's symptoms and health history. However, some common treatments for thyroid gland disorder include medication therapy, surgery, and radiation therapy.
Some of the key players operating in the thyroid gland disorder treatment market are Abbott, bioMƒÂ©rieux, Danaher, DiaSorin, Siemens Healthineers.
The thyroid gland disorder treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thyroid Gland Disorder Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thyroid Gland Disorder Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thyroid Gland Disorder Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thyroid Gland Disorder Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thyroid Gland Disorder Treatment Market Size & Forecast, 2018-2028
4.5.1 Thyroid Gland Disorder Treatment Market Size and Y-o-Y Growth
4.5.2 Thyroid Gland Disorder Treatment Market Absolute $ Opportunity
Chapter 5 Global Thyroid Gland Disorder Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thyroid Gland Disorder Treatment Market Size Forecast by Type
5.2.1 Hyperthyroidism
5.2.2 Hypothyroidism
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thyroid Gland Disorder Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thyroid Gland Disorder Treatment Market Size Forecast by Applications
6.2.1 Men
6.2.2 Women
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thyroid Gland Disorder Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thyroid Gland Disorder Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thyroid Gland Disorder Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Thyroid Gland Disorder Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thyroid Gland Disorder Treatment Market Size Forecast by Type
9.6.1 Hyperthyroidism
9.6.2 Hypothyroidism
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thyroid Gland Disorder Treatment Market Size Forecast by Applications
9.10.1 Men
9.10.2 Women
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thyroid Gland Disorder Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Thyroid Gland Disorder Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thyroid Gland Disorder Treatment Market Size Forecast by Type
10.6.1 Hyperthyroidism
10.6.2 Hypothyroidism
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thyroid Gland Disorder Treatment Market Size Forecast by Applications
10.10.1 Men
10.10.2 Women
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thyroid Gland Disorder Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thyroid Gland Disorder Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thyroid Gland Disorder Treatment Market Size Forecast by Type
11.6.1 Hyperthyroidism
11.6.2 Hypothyroidism
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thyroid Gland Disorder Treatment Market Size Forecast by Applications
11.10.1 Men
11.10.2 Women
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thyroid Gland Disorder Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Thyroid Gland Disorder Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thyroid Gland Disorder Treatment Market Size Forecast by Type
12.6.1 Hyperthyroidism
12.6.2 Hypothyroidism
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thyroid Gland Disorder Treatment Market Size Forecast by Applications
12.10.1 Men
12.10.2 Women
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thyroid Gland Disorder Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thyroid Gland Disorder Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thyroid Gland Disorder Treatment Market Size Forecast by Type
13.6.1 Hyperthyroidism
13.6.2 Hypothyroidism
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thyroid Gland Disorder Treatment Market Size Forecast by Applications
13.10.1 Men
13.10.2 Women
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thyroid Gland Disorder Treatment Market: Competitive Dashboard
14.2 Global Thyroid Gland Disorder Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 bioMérieux
14.3.3 Danaher
14.3.4 DiaSorin
14.3.5 Siemens Healthineers
